Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1955928
Max Phase: Preclinical
Molecular Formula: C62H82N10O12
Molecular Weight: 1159.40
Molecule Type: Small molecule
Associated Items:
ID: ALA1955928
Max Phase: Preclinical
Molecular Formula: C62H82N10O12
Molecular Weight: 1159.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](NC(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCCNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](NC(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
Standard InChI: InChI=1S/C62H82N10O12/c1-5-39(3)51-57(77)65-47(35-41-23-11-7-12-24-41)53(73)63-33-22-20-32-46(68-62(84)70-50(60(81)82)38-44-29-17-10-18-30-44)56(76)72-52(40(4)6-2)58(78)66-48(36-42-25-13-8-14-26-42)54(74)64-34-21-19-31-45(55(75)71-51)67-61(83)69-49(59(79)80)37-43-27-15-9-16-28-43/h7-18,23-30,39-40,45-52H,5-6,19-22,31-38H2,1-4H3,(H,63,73)(H,64,74)(H,65,77)(H,66,78)(H,71,75)(H,72,76)(H,79,80)(H,81,82)(H2,67,69,83)(H2,68,70,84)/t39-,40-,45+,46+,47-,48-,49-,50-,51-,52-/m0/s1
Standard InChI Key: DXOGQWDGTNUZRO-ZBRHJGNSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1159.40 | Molecular Weight (Monoisotopic): 1158.6114 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Cheruku P, Plaza A, Lauro G, Keffer J, Lloyd JR, Bifulco G, Bewley CA.. (2012) Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor., 55 (2): [PMID:22168797] [10.1021/jm201238p] |
Source(1):